Abstract
In this review, estrogenic effects in depression, anxiety, and neurodegenerative disorders are summarized. Moreover, preclinical findings from in vitro and animal models are discussed. There is a correlation between decreased estrogen levels (e.g., premenstrually, during the postpartum period, and perimenopausally) and increased anxiety and depressive symptoms. Several studies show beneficial effects of estrogen treatment in women with anxiety and depressive symptoms. Recent data indicate that the estrogen receptor (ER) β appears to be a major mediator of estrogenic effects in depression and anxiety. Additionally, both preclinical and clinical findings suggest that activation of estrogen receptors have an important role in neuroprotective and neurodegenerative processes in the mammalian central nervous system (CNS).
Similar content being viewed by others
References
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J.-A. (1996). Proc. Natl. Acad. Sci. USA 93(12), 5925–5930.
Imamov, O., Morani, A., Shim, G. J., Omoto, Y., Thulin-Andersson, C., Warner, M., and Gustafsson, J.-A. (2004). Proc. Natl. Acad. Sci. USA 101(25), 9375–9380.
Cheng, G., Weihua, Z., Makinen, S., et al. (2002). Biol. Reprod. 66(1), 77–84.
Wang, L., Andersson, S., Warner, M., and Gustafsson, J.-A. (2001). Proc. Natl. Acad. Sci. USA 98(5), 2792–2796.
Wang, L., Andersson, S., Warner, M., and Gustafsson, J.-A. (2002). Sci. STKE 2002(138), PE29.
Wang, L., Andersson, S., Warner, M., and Gustafsson, J.-A. (2003). Proc. Natl. Acad. Sci. USA 100(2), 703–708.
Reicher-Rossler, A. and Hafner, H. (1993). Eur. Arch. Psychiatry Clin. Neurosci. 242(6), 323–328.
Seeman, M. V. (1996). J. Psychiatry Neurosci. 21(2), 123–127.
Grigoriadis, S. and Seeman, M. V. (2002). Can. J. Psychiatry 47(5), 437–442.
Weissman, M. M., Bland, R., Joyce, P. R., Newman, S., Wells, J. E., and Wittchen, H. U. (1993). J. Affect. Disord. 29(2–3), 77–84.
Kessler, R. C., McGonagle, K. A., Zhao, S., et al. (1994). Arch. Gen. Psychiatry 51(1), 8–19.
Yonkers, K. A. (1997). J. Clin. Psychiatry 58(Suppl. 15), 19–25.
Hendrick, V., Altshuler, L. L., and Suri, R. (1998). Psychosomatics 39(2), 93–101.
Gale, S. and Harlow, B. L. (2003). J. Psychosom. Obstet. Gynaecol. 24(4), 257–266.
Campbell, S. B. and Cohn, J. F. (1991). J. Abnorm. Psychol. 100(4), 594–599.
Robinson, G. E. and Stewart, D. E. (1986). CMAJ 134(1), 31–37.
Pigott, T. A. (1999). J. Clin. Psychiatry 60(Suppl. 18), 4–15.
Kumar, R. and Robson, K. M. (1984). Br. J. Psychiatry 144, 35–47.
Payne, J. L. (2003). Int. Rev. Psychiatry 15(3), 280–290.
Cox, J. L., Murray, D., and Chapman, G. (1993). Br. J. Psychiatry 163, 27–31.
Cooper, P. J., Campbell, E. A., Day, A., Kennerley, H., and Bond, A. (1988). Br. J. Psychiatry 152, 799–806.
McKinlay, S. M., Brambilla, D. J., and Posner, J. G. (1992). Maturitas 14(2), 103–115.
Kessler, R. C., McGonagle, K. A., Swartz, M., Blazer, D. G., and Nelson, C. B. (1993). J. Affect. Disord. 29(2–3), 85–96.
Schmidt, P. J., Roca, C. A., Bloch, M., and Rubinow, D. R. (1997). Semin. Reprod. Endocrinol. 15(1), 91–100.
Hay, A. G., Bancroft, J., and Johnstone, E. C. (1994). Br. J. Psychiatry 164(4), 513–516.
Stewart, D. E., Boydell, K., Derzko, C., and Marshall, V. (1992). Int. J. Psychiatry Med. 22(3), 213–220.
Schmidt, P. J., Haq, N., and Rubinow, D. R. (2004). Am. J. Psychiatry 161(12), 2238–2244.
Grigoriadis, S. and Kennedy, S. H. (2002). Am. J. Ther. 9(6), 503–509.
Herva, A., Jokelainen, J., Pouta, A., et al. (2004). J. Psychosom. Res. 57(4), 359–362.
Epperson, C. N., Wisner, K. L., and Yamamoto, B. (1999). Psychosom. Med. 61(5), 676–697.
Gregoire, A. J., Kumar, R., Everitt, B., Henderson, A. F., and Studd, J. W. (1996). Lancet 347(9006), 930–933.
Ahokas, A., Kaukoranta, J., Wahlbeck, K., and Aito, M. (2001). J. Clin. Psychiatry 62(5), 332–336.
Sichel, D. A., Cohen, L. S., Robertson, L. M., Ruttenberg, A., and Rosenbaum, J. F. (1995). Biol. Psychiatry 38(12), 814–818.
Strickler, R. C., Borth, R., Cecutti, A., et al. (1977). Psychol. Med. 7(4), 631–639.
Morrison, M. F., Kallan, M. J., Ten Have, T., Katz, I., Tweedy, K., and Battistini, M. (2004). Biol. Psychiatry 55(4), 406–412.
Hays, J., Ockene, J. K., Brunner, R. L., et al. (2003). N. Engl. J. Med. 348(19), 1839–1854.
Whooley, M. A., Grady, D., and Cauley, J. A. (2000). J. Gen. Intern. Med. 15(8), 535–541.
Palinkas, L. A. and Barrett-Connor, E. (1992). Obstet. Gynecol. 80(1), 30–36.
Hlatky, M. A., Boothroyd, D., Vittinghoff, E., Sharp, P., and Whooley, M. A. (2002). JAMA 287(5), 591–597.
Schiff, R., Bulpitt, C. J., Wesnes, K. A. and Rajkumar, C. (2005). Psychoneuroendocrinology 30(4), 309–315.
Schmidt, P. J., Nieman, L., Danaceau, M. A., et al. (2000). Am. J. Obstet. Gynecol. 183(2), 414–420.
Soares, C. N., Almeida, O. P., Joffe, H., and Cohen, L. S. (2001). Arch. Gen. Psychiatry 58(6), 529–534.
Rossouw, J. E., Anderson, G. L., Prentice, R. L., et al. (2002). JAMA 288(3), 321–333.
Stewart, D. E., Rolfe, D. E., and Robertson, E. (2004). Psychosomatics 45(5), 445–447.
Couse, J. F., Lindzey, J., Grandien, K., Gustafsson, J.-A., and Korach, K. S. (1997). Endocrinology 138(11), 4613–4621.
Kuiper, G., Carlsson, G., Grandien, B., et al. (1997). Endocrinology 138(3), 863–870.
Osterlund, M. K., Gustafsson, J.-A., Keller, E., and Hurd, Y. L. (2000). J. Clin. Endocrinol. Metab. 85(10), 3840–3846.
Harris, H. A., Katzenellenbogen, J. A., and Katzenellenbogen, B. S. (2002). Endocrinology 143(11), 4172–4177.
Lund, T. D., Rovis, T., Chung, W. C., and Handa, R. J. (2005). Endocrinology 146(2), 797–807.
Walf, A. A., Rhodes, M. E., and Frye, C. A. (2004). Pharmacol. Biochem. Behav. 78(3), 523–529.
Meyers, M. J., Sun, J., Carlson, K. E., Marriner, G. A., Katzenellenbogen, B. S., and Katzenellenbogen, J. A. (2001). J. Med. Chem. 44(24), 4230–4251.
Stauffer, S. R., Coletta, C. J., Tedesco, R., et al. (2000). J. Med. Chem. 43(26), 4934–4947.
Rocha, B. A., Fleischer, R., Schaeffer, J. M., Rohrer, S. P., and Hickey, G. J. (2005). Psychopharmacology (Berl.) 179(3), 637–643.
Bethea, C. L., Mirkes, S. J., Shively, C. A., and Adams, M. R. (2000). Biol. Psychiatry 47(6), 562–576.
Fink, G., Sumner, B. E., Rosie, R., Grace, O., and Quinn, J. P. (1996). Cell. Mol. Neurobiol. 16(3), 325–344.
Lu, N. Z., Shlaes, T. A., Gundlah, C., Dziennis, S. E., Lyle, R. E., and Bethea, C. L. (1999). Endocrine 11(3), 257–267.
Osterlund, M. K., Halldin, C., and Hurd, Y. L. (2000). Synapse 35(1), 39–44.
Osterlund, M. K. and Hurd, Y. L. (1998). Brain Res. Mol. Brain Res. 55(1), 169–172.
Gundlah, C., Alves, S. E., Clark, J. A., Pai, L. Y., Schaeffer, J. M., and Rohrer, S. P. (2005). Biol. Psychiatry 57(8), 938–942.
Nomura, M., Akama, K. T., Alves, S. E., et al. (2005). Neuroscience 130(2), 445–456.
Walther, D. J., Peter, J. U., Bashammakh, S., et al. (2003). Science 299(5603), 76.
Clark, J. A., Pai, L. Y., Flick, R. B., and Rohrer, S. P. (2005). Biol. Psychiatry 57(8), 943–946.
Sanchez, R. L., Reddy, A. P., Centeno, M. L., Henderson, J. A., and Bethea, C. L. (2005). Brain Res. Mol. Brain Res. 135(1–2), 194–203.
Krezel, W., Dupont, S., Krust, A., Chambon, P., and Chapman, P. F. (2001). Proc. Natl. Acad. Sci. USA 98(21), 12278–12282.
Imwalle, D. B., Gustafsson, J.-A., and Rissman, E. F. (2005). Physiol. Behav. 84(1), 157–163.
Lee, S. J. and McEwen, B. S. (2001). Ann. Rev. Pharmacol. Toxicol. 41, 569–591.
Selkoe, D. J. and Schenk, D. (2003). Ann. Rev. Pharmacol. Toxicol. 43, 545–584.
Roth, M. P., Clayton, J., Patois, E., and Alperovitch, A. (1994). Neuroepidemiology 13, 211–215.
Saunders-Pullman, R., Gordon-Elliott, J., Parides, M., Fahn, S., Saunders, H. R., and Bressman, S. (1999). Neurology 52(7), 1417–1421.
Atwood, C. S. (2005). Cell. Mol. Life Sci. 62(3), 255–256.
Alkayed, N. J., Harukuni, I., Kimes, A. S., London, E. D., Traystman, R. J., and Hurn, P. D. (1998). Stroke 29(1), 159–165; discussion 166.
Culmsee, C., Vedder, H., Ravati, A., et al. (1999). J. Cereb. Blood Flow Metab. 19(11), 1263–1269.
McEwen, B. (2002). Recent Prog. Horm. Res. 57, 357–384.
Sherwin, B. B. (2003). J. Mol. Neurosci. 20(3), 385–393.
Matsumoto, A. and Arai, Y. (1981). J. Comp. Neurol. 197(2), 197–205.
Singh, M., Setalo, G. Jr., Guan, X., Warren, M., and Toran-Allerand, C. D. (1999). J. Neurosci. 19(4), 1179–1188.
Toran-Allerand, C. D. (2004). Endocrinology 145(3), 1069–1074.
Toran-Allerand, C. D., Guan, X., MacLusky, N. J., et al. (2002). J. Neurosci. 22(19), 8391–8401.
Green, P. S., Yang, S. H., and Simpkins, J. W. (2000). Novartis Found Symp. 230, 202–213.
Marin, R., Guerra, B., Morales, A., Diaz, M., and Alonso, R. (2003). Ann. NY Acad. Sci. 1007, 108–116.
Krishnan, K., Campbell, S., Abdel-Rahman, F., Whaley, S., and Stone, W. L. (2003). Curr. Drug Targets 4(1), 45–54.
Simpkins, J. W., Yang, S. H., Wen, Y., and Singh, M. (2005). Cell. Mol. Life Sci. 62(3), 271–280.
Behl, C. and Moosmann, B. (2002). Biol. Chem. 383(3–4), 521–536.
Rao, A. V. and Balachandran, B. (2002). Nutr. Neurosci. 5(5), 291–309.
Behl, C., Widmann, M., Trapp, T., and Holsboer, F. (1995). Biochem. Biophys. Res. Commun. 216(2), 473–482.
Chaban, V. V., Mayer, E. A., Ennes, H. S., and Micevych, P. E. (2003). Neuroscience 118(4), 941–948.
Mermelstein, P. G., Becker, J. B., and Surmeier, D. J. (1996). J. Neurosci. 16(2), 595–604.
Lewen, A., Matz, P., and Chan, P. H. (2000). J. Neurotrauma 17(10), 871–890.
Bayir, H., Marion, D. W., Puccio, A. M., et al. (2004). J. Neurotrauma 21(1), 1–8.
Sekhon, L. H. and Fehlings, M. G. (2001). Spine 26(24 Suppl.), S2–12.
Singer, C. A., Figueroa-Masot, X. A., Batchelor, R. H., and Dorsa, D. M. (1999). J. Neurosci. 19(7), 2455–2463.
Jover, T., Tanaka, H., Calderone, A., et al. (2002). J. Neurosci. 22(6), 2115–2124.
Koski, C. L., Hila, S., and Hoffman, G. E. (2004). Endocrinology 145(1), 95–103.
Jung, Y. S., Lee, B. K., Park, H. S., et al. (2005). Neuroreport 16(7), 741–744.
Ospina, J. A., Brevig, H. N., Krause, D. N., and Duckles, S. P. (2004). Am. J. Physiol. Heart Circ. Physiol. 286(5), H2010-H2019.
Vegeto, E., Belcredito, S., Etteri, S., et al. (2003). Proc. Natl. Acad. Sci. USA 100(16), 9614–9619.
Polanczyk, M., Zamora, A., Subramanian, S., et al. (2003). Am. J. Pathol. 163(4), 1599–1605.
Fridmacher, V., Kaltschmidt, B., Goudeau, B., et al. (2003). J. Neurosci. 23(28), 9403–9408.
Castagne, V., Lefevre, K., and Clarke, P. G. (2001). Neuroscience 108(3), 517–526.
O’Neill, L. A. and Kaltschmidt, C. (1997). Trends Neurosci. 20, 252–258.
Ghisletti, S., Meda, C., Maggi, A., and Vegeto, E. (2005). Mol. Cell. Biol. 25(8), 2957–2968.
Dodel, R. C., Du, Y., Bales, K. R., Gao, F., and Paul, S. M. (1999). J. Neurochem. 73(4), 1453–1460.
Harnish, D. C., Scicchitano, M. S., Adelman, S. J., Lyttle, C. R., and Karathanasis, S. K. (2000). Endocrinology 141, 3403–3411.
Speir, E., Yu, Z. X., Takeda, K., Ferrans, V. J., and Cannon, R. O. 3rd (2000). Circulation 102(24), 2990–2996.
Jaffe, A. B., Toran-Allerand, C. D., Greengard, P., and Gandy, S. E. (1994). J. Biol. Chem. 269(18), 13,065–13,068.
Greenfield, J. P., Leung, L. W., Cai, D., et al. (2002). J. Biol. Chem. 277(14), 12128–12136.
Li, R., Shen, Y., Yang, L. B., Lue, L. F., Finch, C., and Rogers, J. (2000). J. Neurochem. 75(4), 1447–1454.
Xu, H., Gouras, G. K., Greenfield, J. P., et al. (1998). Nat. Med. 4(4), 447–451.
Kugaya, A., Epperson, C. N., Zoghbi, S., et al. (2003). Am. J. Psychiatry 160(8), 1522–1524.
Duka, T., Tasker, R., and McGowan, J. F. (2000). Psychopharmacology (Berl.) 149(2), 129–139.
Hogervorst, E., Boshuisen, M., Riedel, W., Willeken, C., and Jolles, J. (1999). Psychoneuroendocrinology 24(1), 43–68.
Sherwin, B. B. (1988). Psychoneuroendocrinology 13(4), 345–357.
Phillips, S. M. and Sherwin, B. B. (1992). Psychoneuroendocrinology 17(5), 485–495.
Saletu, B. (2003). Climacteric 6(Suppl. 2), 37–45.
Anderson, G. L., Limacher, M., Assaf, A. R., et al. (2004). JAMA 291(14), 1701–1712.
Lacey, J. V. Jr., Mink, P. J., Lubin, J. H., et al. (2002). JAMA 288(3), 334–341.
Rapp, S. R., Espeland, M. A., Shumaker, S. A., et al. (2003). JAMA 289(20), 2663–2672.
Shumaker, S. A., Legault, C., Rapp, S. R., et al. (2003). JAMA 289(20), 2651–2662.
Wise, P. M., Dubal, D. B., Rau, S. W., Brown, C. M., and Suzuki, S. (2005). Endocr. Rev. 26, 308–312.
Hersh, A. L., Stefanick, M. L., and Stafford, R. S. (2004). JAMA 291(1), 47–53.
Bhavnani, B. R. (2003). J. Steroid Biochem. Mol. Biol. 85 (2–5), 473–482.
Bhavnani, B. R., Nisker, J. A., Martin, J., Aletebi, F., Watson, L., and Milne, J. K. (2000). J. Soc. Gynecol. Investig. 7(3), 175–183.
Honjo, H., Ogino, Y., Tanaka, K., Urabe, M., Kashiwagi, T., and Ishihara, S. (1993). J. Jap. Mneop. Soc. 1, 167–171.
Asthana, S., Craft, S., Baker, L. D., et al. (1999). Psychoneuroendocrinology 24(6), 657–677.
Asthana, S., Baker, L. D., Craft, S., et al. (2001). Neurology 57(4), 605–612.
Gleason, C. E., Cholerton, B., Carlsson, C. M., Johnson, S. C., and Asthana, S. (2005). Cell. Mol. Life Sci. 62(3), 299–312.
Resnick, S. M. and Maki, P. M. (2001). Ann. NY Acad. Sci. 949, 203–214.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Österlund, M.K., Witt, MR. & Gustafsson, JÅ. Estrogen action in mood and neurodegenerative disorders. Endocr 28, 235–241 (2005). https://doi.org/10.1385/ENDO:28:3:235
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:28:3:235